Maria Restrepo1, Lucia Mirabella1, Elaine Tang2, Christopher M Haggerty1, Reza H Khiabani1, Francis Fynn-Thompson3, Anne Marie Valente3, Doff B McElhinney3, Mark A Fogel4, Ajit P Yoganathan5. 1. The Wallace H. Coulter Department of Biomedical Engineering at Georgia Institute of Technology and Emory University, Atlanta, Georgia. 2. School of Chemical and Biomolecular Engineering, Georgia Institute of Technology, Atlanta, Georgia. 3. Department of Cardiology, Boston Children's Hospital, Boston, Massachusetts. 4. Division of Cardiology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania. 5. The Wallace H. Coulter Department of Biomedical Engineering at Georgia Institute of Technology and Emory University, Atlanta, Georgia. Electronic address: ajit.yoganathan@bme.gatech.edu.
Abstract
BACKGROUND: Typically, a Fontan connection is constructed as either a lateral tunnel (LT) pathway or an extracardiac (EC) conduit. The LT is formed partially by atrial wall and is assumed to have growth potential, but the extent and nature of LT pathway growth have not been well characterized. A quantitative analysis was performed to evaluate this issue. METHODS: Retrospective serial cardiac magnetic resonance data were obtained for 16 LT and 9 EC patients at 2 time points (mean time between studies, 4.2 ± 1.6 years). Patient-specific anatomies and flows were reconstructed. Geometric parameters of Fontan pathway vessels and the descending aorta were quantified, normalized to body surface area (BSA), and compared between time points and Fontan pathway types. RESULTS: Absolute LT pathway mean diameters increased over time for all but 2 patients; EC pathway size did not change (2.4 ± 2.2 mm vs 0.02 ± 2.1 mm, p < 0.05). Normalized LT and EC diameters decreased, while the size of the descending aorta increased proportionally to BSA. Growth of other cavopulmonary vessels varied. The patterns and extent of LT pathway growth were heterogeneous. Absolute flows for all vessels analyzed, except for the superior vena cava, proportionally to BSA. CONCLUSIONS: Fontan pathway vessel diameter changes over time were not proportional to somatic growth but increases in pathway flows were; LT pathway diameter changes were highly variable. These factors may impact Fontan pathway resistance and hemodynamic efficiency. These findings provide further understanding of the different characteristics of LT and EC Fontan connections and set the stage for further investigation.
BACKGROUND: Typically, a Fontan connection is constructed as either a lateral tunnel (LT) pathway or an extracardiac (EC) conduit. The LT is formed partially by atrial wall and is assumed to have growth potential, but the extent and nature of LT pathway growth have not been well characterized. A quantitative analysis was performed to evaluate this issue. METHODS: Retrospective serial cardiac magnetic resonance data were obtained for 16 LT and 9 ECpatients at 2 time points (mean time between studies, 4.2 ± 1.6 years). Patient-specific anatomies and flows were reconstructed. Geometric parameters of Fontan pathway vessels and the descending aorta were quantified, normalized to body surface area (BSA), and compared between time points and Fontan pathway types. RESULTS: Absolute LT pathway mean diameters increased over time for all but 2 patients; EC pathway size did not change (2.4 ± 2.2 mm vs 0.02 ± 2.1 mm, p < 0.05). Normalized LT and EC diameters decreased, while the size of the descending aorta increased proportionally to BSA. Growth of other cavopulmonary vessels varied. The patterns and extent of LT pathway growth were heterogeneous. Absolute flows for all vessels analyzed, except for the superior vena cava, proportionally to BSA. CONCLUSIONS: Fontan pathway vessel diameter changes over time were not proportional to somatic growth but increases in pathway flows were; LT pathway diameter changes were highly variable. These factors may impact Fontan pathway resistance and hemodynamic efficiency. These findings provide further understanding of the different characteristics of LT and EC Fontan connections and set the stage for further investigation.
Authors: David H Frakes; Christopher P Conrad; Timothy M Healy; Joseph W Monaco; Mark Fogel; Shiva Sharma; Mark J T Smith; Ajit P Yoganathan Journal: IEEE Trans Biomed Eng Date: 2003-02 Impact factor: 4.538
Authors: F Fontan; G Fernandez; F Costa; D C Naftel; F Tritto; E H Blackstone; J W Kirklin Journal: J Thorac Cardiovasc Surg Date: 1989-11 Impact factor: 5.209
Authors: A M Mendelsohn; E L Bove; F M Lupinetti; D C Crowley; T R Lloyd; R H Beekman Journal: J Thorac Cardiovasc Surg Date: 1994-05 Impact factor: 5.209
Authors: S Nakata; Y Imai; Y Takanashi; H Kurosawa; K Tezuka; M Nakazawa; M Ando; A Takao Journal: J Thorac Cardiovasc Surg Date: 1984-10 Impact factor: 5.209
Authors: John M Kelly; Gabriel J M Mirhaidari; Yu-Chun Chang; Toshiharu Shinoka; Christopher K Breuer; Andrew R Yates; Kan N Hor Journal: Pediatr Cardiol Date: 2020-11-08 Impact factor: 1.655
Authors: Jiyong Moon; Li Shen; Donald S Likosky; Vikram Sood; Reilly D Hobbs; Peter Sassalos; Jennifer C Romano; Richard G Ohye; Edward L Bove; Ming-Sing Si Journal: J Am Coll Cardiol Date: 2020-07-28 Impact factor: 24.094
Authors: Friso M Rijnberg; Séline F S van der Woude; Mark G Hazekamp; Pieter J van den Boogaard; Hildo J Lamb; Covadonga Terol Espinosa de Los Monteros; Lucia J M Kroft; Sasa Kenjeres; Tawab Karim; Monique R M Jongbloed; Jos J M Westenberg; Jolanda J Wentzel; Arno A W Roest Journal: Eur J Cardiothorac Surg Date: 2022-06-15 Impact factor: 4.534
Authors: Sjoerd S M Bossers; Merih Cibis; Livia Kapusta; Wouter V Potters; Miranda M Snoeren; Jolanda J Wentzel; Adriaan Moelker; Willem A Helbing Journal: Pediatr Cardiol Date: 2016-01-12 Impact factor: 1.655
Authors: Erica L Schwarz; John M Kelly; Kevin M Blum; Kan N Hor; Andrew R Yates; Jacob C Zbinden; Aekaansh Verma; Stephanie E Lindsey; Abhay B Ramachandra; Jason M Szafron; Jay D Humphrey; Toshiharu Shin'oka; Alison L Marsden; Christopher K Breuer Journal: NPJ Regen Med Date: 2021-07-22